Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Charlie Smith who wrote (633)	7/9/1998 4:25:00 PM
From: Jim Mac	Read Replies (2) \| Respond to of 1754

Charlie, It seems to me earnings will much better than expected, like $0.55 - $0.65 before the Summit payoff. And with PPP out of the picture, S2 upgrade/lasers hitting the market, Q3/Q4 look even better. No more FTC worries, and hyperopia approval coming, future earnings outlook looks even better. $2.00 trailing EPS as of end of July before one-time charges, and $3.00/$4.00 for 1999 put VISX at a fair value of $70 now and $100/$140 in 1999, assuming a P/E of 35. It's a little like YHOO: as more people do it, they realize how great it is, and they call their broker.